Deutsche Bank AG Acquires New Holdings in Enovix Corporation $ENVX

Deutsche Bank AG acquired a new position in Enovix Corporation (NASDAQ:ENVX) in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 550,710 shares of the company’s stock, valued at approximately $3,343,000.

A number of other hedge funds also recently bought and sold shares of the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in shares of Enovix by 5.1% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 98,318 shares of the company’s stock valued at $722,000 after buying an additional 4,780 shares during the last quarter. NewEdge Advisors LLC boosted its holdings in shares of Enovix by 10.4% in the 1st quarter. NewEdge Advisors LLC now owns 26,257 shares of the company’s stock valued at $193,000 after buying an additional 2,481 shares in the last quarter. Goldman Sachs Group Inc. grew its position in shares of Enovix by 65.4% in the 1st quarter. Goldman Sachs Group Inc. now owns 1,137,777 shares of the company’s stock worth $8,351,000 after buying an additional 449,934 shares during the last quarter. Caxton Associates LLP purchased a new position in shares of Enovix in the 1st quarter worth approximately $190,000. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in shares of Enovix by 18.4% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 358,023 shares of the company’s stock worth $2,628,000 after acquiring an additional 55,676 shares in the last quarter. Hedge funds and other institutional investors own 50.92% of the company’s stock.

Enovix Price Performance

NASDAQ ENVX opened at $3.40 on Thursday. The company has a debt-to-equity ratio of 2.46, a current ratio of 9.71 and a quick ratio of 9.37. The stock’s fifty day moving average price is $4.79 and its 200 day moving average price is $5.67. Enovix Corporation has a 1 year low of $3.06 and a 1 year high of $14.21. The company has a market cap of $746.13 million, a price-to-earnings ratio of -4.20 and a beta of 2.32.

Enovix (NASDAQ:ENVX) last issued its earnings results on Wednesday, August 12th. The company reported ($0.13) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.15) by $0.02. Enovix had a negative return on equity of 64.50% and a negative net margin of 473.89%.The company had revenue of $9.02 million during the quarter, compared to analyst estimates of $8.43 million. During the same quarter last year, the business posted ($0.13) EPS. The firm’s quarterly revenue was up 20.8% on a year-over-year basis. Enovix has set its Q3 2026 guidance at -0.170–0.130 EPS. As a group, equities research analysts forecast that Enovix Corporation will post -0.8 earnings per share for the current year.

Analyst Ratings Changes

ENVX has been the subject of a number of analyst reports. Benchmark decreased their target price on shares of Enovix from $25.00 to $15.00 and set a “buy” rating for the company in a research report on Thursday, May 14th. B. Riley Financial cut their price target on shares of Enovix from $10.00 to $9.00 and set a “buy” rating on the stock in a report on Thursday, August 13th. Wall Street Zen downgraded Enovix from a “sell” rating to a “strong sell” rating in a research report on Saturday, August 22nd. William Blair lowered Enovix from an “outperform” rating to a “market perform” rating in a report on Monday, August 17th. Finally, JPMorgan Chase & Co. lowered Enovix from a “neutral” rating to an “underweight” rating in a report on Wednesday, May 6th. One analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, three have given a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $11.77.

Enovix Company Profile

Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.

Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.